In 2018 drugs for rare conditions such as betathalassemia made it onto the approval mainstage in addition to drugs for more common diseases such as cancer. Check out our list of these and other treatments that made headlines this year httpbit.ly2

In 2018, drugs for rare conditions such as beta-thalassemia made it onto the approval mainstage in addition to drugs for more common diseases such as #cancer. Check out our list of these and other treatments that made headlines this year: http://bit.ly/2

In 2018, drugs for rare conditions such as beta-thalassemia made it onto the approval mainstage in addition to drugs for more common diseases such as #cancer. Check out our list of these and other treatments that made headlines this year: http://bit.ly/2Gafr6Z 

More From BioPortfolio on "In 2018, drugs for rare conditions such as beta-thalassemia made it onto the approval mainstage in addition to drugs for more common diseases such as #cancer. Check out our list of these and other treatments that made headlines this year: http://bit.ly/2"